(AS

SECTION 2: Hazards identification

EMERGENCY OVERVIEW: THIS PRODUCT IS A COLORLESS, ODORLESS, FLAMMABLE LIQUID IN A PRESSURIZED CAN, WITH CARBON DIOXIDE AS A PROPELLANT.

Health hazards

THE ASSOCIATED WITH OVEREXPOSURE ARE MINIMAL, DUE TO THE SMALL SIZE OF THE CONTAINER AND SMALL VOLUME OF IF A RELEASE OF MANY CONTAINERS OF THIS PRODUCT OCCURS AT THE SAME TIME, INHALATION MAY CAUSE CENTRAL NERVOUS SYSTEM DEPRESSION. IN ADDITION, UNDER THESE CIRCUMSTANCES AN OXYGEN-DEFICIENT ENVIRONMENT CAN OCCUR, RESULTING IN A HAZARD OF ASPHYXIATION. IF THE CONTAINER IS HEATED OR PUNCTURED, RUPTURE OF THE CONTAINER MAY OCCUR, AND MAY CAUSE INJURY. FROSTBITE CAN BE CAUSED BY CONTACT WITH RAPIDLY EXPANDING GASES. PLAMMABILITY HAZARDS: DUE TO THE HIGH LEVEL OF ISOPROPANOL IN THIS PRODUCT, IT MUST BE CONSIDERED AS FLAMMABLE. VAPORS OF THIS PRODUCT ARE HEAVIER THAN AIR AND MAY SPREAD LONG DISTANCES; DISTANT IGNITION AND FLASH-BACK ARE POSSIBLE. REACTIVITY HAZARDS: THIS PRODUCT IS NOT REACTIVE. (BLUE) 1 FLAMMABILITY HAZARD (RED) 3

Contains

THE LIQUID IS IN SUCH SMALL QUANTITY THAT IT DOES NOT NORMALLY PRESENT

Environmental hazards

RELEASE OF THIS PRODUCT TO IS NOT EXPECTED TO CAUSE HARM UNLESS A LARGE QUANTITY OF CONTAINERS IS RELEASED. EMERGENCY RECOMMENDATIONS: PERSONS RESPONDING TO AN EMERGENCY SUCH AS A FIRE THAT INVOLVES THIS PRODUCT MUST TAKE

Precautionary statements

TO AVOID POTENTIAL INJURY FROM CONTAINERS THAT RUPTURE AND FOR THE FLAMMABILITY OF THE PRODUCT. EC CLASSIFICATION DUE TO THE OVERALL SMALL AMOUNT OF PRODUCT CONTAINED IN EACH CAN LESS THAN 10 ML), NO CLASSIFICATION OF THIS PRODUCT IS REQUIRED, PER COUNCIL DIRECTIVE 83/265/EEC, 16 MAY, 1983, ARTICLE 6, RISK PHRASES NOT APPLICABLE SAFETY PHRASES NOT APPLICABLE SYMPTOMS OF OVER-EXPOSURE BY ROUTE OF EXPOSURE CONTACT WITH THIS PRODUCT IS NOT EXPECTED TO CAUSE SIGNIFICANT ADVERSE HEALTH EFFECTS, DUE TO THE SMALL SIZE OF CONTAINER AND LIMITED AMOUNT OF GAS WITHIN THE CONTAINER INHALATION INHALATION OF VAPORS CAN IRRITATE THE MUCOUS MEMBRANES, THE NOSE, THROAT AND RESPIRATORY TRACT HUMAN SYSTEMIC EFFECTS FOLLOWING EXPOSURE VIA INHALATION AND INGESTION) INCLUDE FLUSHING, PULSE RATE DECREASE, LOWERING OF BLOOD PRESSURE, HEADACHE, ANESTHESIA, NARCOSIS, DIZZINESS, MENTAL DEPRESSION, HALLUCINATIONS, DISTORTED PERCEPTIONS, DYSPNEA, RESPIRATORY DEPRESSION, NAUSEA OR VOMITING AND IN EXTREME CASES, COMA HAVE BEEN REPORTED FOR THE MAIN COMPONENT, ISOPROPANOL. HIGH CONCENTRATIONS OF VAPORS, AS MAY OCCUR IF THE PRODUCT IS USED OR RELEASED IN A POORLY-VENTILATED AREA OR CONFINED SPACE (OR DURING A RELEASE OF LARGE VOLUMES OF THIS PRODUCT), CAN CAUSE UNCONSCIOUSNESS. IN ADDITION, SUCH CONDITIONS MAY PRODUCE AN OXYGEN-DEFICIENT ENVIRONMENT. INDIVIDUALS BREATHING SUCH AN ATMOSPHERE MAY EXPERIENCE SYMPTOMS WHICH INCLUDE HEADACHES, RINGING IN EARS, DIZZINESS, DROWSINESS, UNCONSCIOUSNESS, NAUSEA, VOMITING, AND DEPRESSION OF ALL THE SENSES. UNDER SOME CIRCUMSTANCES OF OVEREXPOSURE, DEATH MAY OCCUR. THE EFFECTS ASSOCIATED WITH VARIOUS LEVELS OF OXYGEN ARE AS FOLLOWS: CONCENTRATION OF OXYGEN OBSERVED EFFECT 12-16% OXYGEN BREATHING AND PULSE RATE INCREASE, MUSCULAR COORDINATION SLIGHTLY DISTURBED. 10-14% OXYGEN EMOTIONAL UPSET, ABNORMAL FATIGUE, DISTURBED RESPIRATION. 6-10% OXYGEN NAUSEA, VOMITING, COLLAPSE, OR LOSS OF CONSCIOUSNESS. BELOW 6% CONVULSIVE MOVEMENTS, POSSIBLE RESPIRATORY COLLAPSE, AND DEATH. VAPORS OF THIS PRODUCT ARE HEAVIER THAN AIR. HIGH CONCENTRATIONS CAN ACCUMULATE IN LOW-LYING AREAS, RESULTING IN A HAZARD OF INHALATION OF AN OXYGEN-DEFICIENT ATMOSPHERE, WHICH MAY BE FATAL. CONTACT WITH SKIN OR EYES: CONTACT OF THIS PRODUCT WITH THE SKIN IS NOT EXPECTED TO CAUSE ADVERSE EPFECT. IF THIS PRODUCT IS SPRAYED OR RELEASED DIRECTLY INTO THE EYES OR TO THE SKIN, FROSTBITE MAY OCCUR, WITH DAMAGE TO TISSUE. REPEATED SKIN CONTACT MAY CAUSE DEFATTING OF THE SKIN, RESULTING IN DERMATITIS, WITH DRY, RED, ITCHY SKIN. INGESTION: NOT A LIKELY

Potential health effects

OR RISKS FROM EXPOSURE: AN EXPLANATION IN LAY TERMS. OVER-EXPOSURE TO THIS GAS MIXTURE MAY CAUSE THE FOLLOWING HEALTH EFFECTS. ACUTE: THERE ARE NO ANTICIPATED ACUTE EFFECTS AFTER EXPOSURE TO THIS PRODUCT. IN THE EVENT THAT A VERY LARGE NUMBER OF CONTAINERS ARE RELEASED SIMULTANEOUSLY, ADVERSE EFFECTS ON THE CENTRAL NERVOUS SYSTEM AND IRRITATION MAY OCCUR AND AN OXYGEN-DEFICIENT ENVIRONMENT MAY BE PRODUCED. CHRONIC: CHRONIC EXPOSURE TO THIS PRODUCT MAY CAUSE DERMATITIS TO THE SKIN. TARGET ORGANS: ACUTE: EYES, RESPIRATORY SYSTEM, CARDIOVASCULAR AND CENTRAL NERVOUS SYSTEMS. CHRONIC: SKIN. HAZARDOUS MATERIAL IDENTIFICATION SYSTEM

Physical hazards

(YELLOW) 0O PROTECTIVE EQUIPMENT EYES: CHEMICAL GOGGLES RESPIRATORY: SEE SECTION 8 HANDS: GLOVES BODY: SEE SECTION 8 FOR ROUTINE INDUSTRIAL USE AND HANDLING APPLICATIONS SEE ORIGINAL MSDS FOR DEFINITION OF RATINGS

2.1 Classification of the substance or mixture

DUE TO THE OVERALL SMALL AMOUNT OF PRODUCT CONTAINED IN EACH CAN (LESS THAN 10 ML), NO CLASSIFICATION OF THIS PRODUCT IS REQUIRED, PER COUNCIL DIRECTIVE 83/265/EEC, 16 MAY, 1983, ARTICLE 6, 6 RISK PHRASES: NOT APPLICABLE. SAFETY PHRASES: NOT APPLICABLE. SYMPTOMS OF OVER-EXPOSURE BY ROUTE OF EXPOSURE: CONTACT WITH THIS PRODUCT IS NOT EXPECTED TO CAUSE SIGNIFICANT ADVERSE HEALTH EFFECTS, DUE TO THE SMALL SIZE OF CONTAINER AND LIMITED AMOUNT OF GAS WITHIN THE CONTAINER. INHALATION: INHALATION OF VAPORS CAN IRRITATE THE MUCOUS MEMBRANES, THE NOSE, THROAT AND RESPIRATORY TRACT. HUMAN SYSTEMIC EFFECTS FOLLOWING EXPOSURE VIA INHALATION (AND INGESTION) INCLUDE FLUSHING, PULSE RATE DECREASE, LOWERING OF BLOOD PRESSURE, HEADACHE, ANESTHESIA, NARCOSIS, DIZZINESS, MENTAL DEPRESSION, HALLUCINATIONS, DISTORTED PERCEPTIONS, DYSPNEA, RESPIRATORY DEPRESSION, NAUSEA OR VOMITING AND IN EXTREME CASES, COMA HAVE BEEN REPORTED FOR THE